Literature DB >> 22613495

Kinetics of parasite burdens in blood and tissues during murine toxoplasmosis.

Olgica Djurković-Djaković1, Vitomir Djokić, Marija Vujanić, Tijana Zivković, Branko Bobić, Aleksandra Nikolić, Ksenija Slavić, Ivana Klun, Vladimir Ivović.   

Abstract

A sensitive real-time PCR technique was used to examine the distribution of Toxoplasma gondii in the blood and tissues of mice during acute and chronic infection. Groups of Swiss Albino mice, inoculated i.p. with 10(2) or 10(6) tachyzoites of the RH strain as a typical type-1 strain, or fed 10 cysts of the Me49 strain as a typical type-2 strain, were killed at different time points post-infection (p.i.), and blood and organs including the lungs, brain and liver were harvested for DNA extraction. Toxoplasma DNA was quantified by a real-time PCR targeted at the 529bp gene fragment, with a detection limit of a single parasite per g/ml of tissue. The results showed a strain- and dose-dependent spread of Toxoplasma. In infection with type-1 parasites, in case of a high infective dose, Toxoplasma DNA was detected within 24h p.i. in all analyzed tissues including the brain. Conversely, in case of a low infective dose, parasitaemia was undetectable early p.i., at a time when Toxoplasma DNA was detected in the tissues, but reached very high levels as infection progressed. With both infective doses, pre-death parasite burdens were higher in the blood than in the tissues, whereas the same loads in the lungs suggest that reaching these Toxoplasma burdens may be critical for survival. In infection with Me49 parasites, steady high parasite burdens were noted up to the end of the experiment at d42 only in the brain, parasitaemia was low but detectable throughout, and Toxoplasma DNA was completely cleared only from the liver. These data are important to better understand the pathogenesis of toxoplasmosis, and also as baseline data for the experimental evaluation of novel chemotherapeutics.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22613495     DOI: 10.1016/j.exppara.2012.05.006

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  15 in total

1.  PCR-based diagnosis is not always useful in the acute acquired toxoplasmosis in immunocompetent individuals.

Authors:  Elizabeth Souza Neves; Otavio Melo Espíndola; André Curi; Maria Regina Amendoeira; Danielle Nascimento Rocha; Leonardo Henrique Ferreira Gomes; Letícia Cunha Guida
Journal:  Parasitol Res       Date:  2021-01-08       Impact factor: 2.289

2.  Differential Gamma Interferon- and Tumor Necrosis Factor Alpha-Driven Cytokine Response Distinguishes Acute Infection of a Metatherian Host with Toxoplasma gondii and Neospora caninum.

Authors:  Shannon L Donahoe; David N Phalen; Bronwyn M McAllan; Denis O'Meally; Milton M McAllister; John Ellis; Jan Šlapeta
Journal:  Infect Immun       Date:  2017-05-23       Impact factor: 3.441

3.  microRNA-155 Expression and Butyrylcholinesterase Activity in the Liver Tissue of Mice Infected with Toxoplasma gondii (Avirulent and Virulent Strains).

Authors:  Mona El-Sayad; Mohamed Abdel Rahman; Neveen Hussein; Rawda Abdel Aziz; Hend A El-Taweel; Naglaa Abd El-Latif
Journal:  Acta Parasitol       Date:  2021-04-11       Impact factor: 1.440

4.  Global Metabolomic Profiling of Mice Brains following Experimental Infection with the Cyst-Forming Toxoplasma gondii.

Authors:  Chun-Xue Zhou; Dong-Hui Zhou; Hany M Elsheikha; Guang-Xue Liu; Xun Suo; Xing-Quan Zhu
Journal:  PLoS One       Date:  2015-10-02       Impact factor: 3.240

5.  Prime-boost vaccination with toxoplasma lysate antigen, but not with a mixture of recombinant protein antigens, leads to reduction of brain cyst formation in BALB/c mice.

Authors:  Angelika Wagner; Irma Schabussova; Bärbel Ruttkowski; Roman Peschke; Józef Kur; Michael Kundi; Anja Joachim; Ursula Wiedermann
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

6.  SAR Studies of 5-Aminopyrazole-4-carboxamide Analogues as Potent and Selective Inhibitors of Toxoplasma gondii CDPK1.

Authors:  Wenlin Huang; Kayode K Ojo; Zhongsheng Zhang; Kasey Rivas; Rama Subba Rao Vidadala; Suzanne Scheele; Amy E DeRocher; Ryan Choi; Matthew A Hulverson; Lynn K Barrett; Igor Bruzual; Latha Kallur Siddaramaiah; Keshia M Kerchner; Matthew D Kurnick; Gail M Freiberg; Dale Kempf; Wim G J Hol; Ethan A Merritt; Georg Neckermann; Eugenio L de Hostos; Nina Isoherranen; Dustin J Maly; Marilyn Parsons; J Stone Doggett; Wesley C Van Voorhis; Erkang Fan
Journal:  ACS Med Chem Lett       Date:  2015-10-22       Impact factor: 4.345

7.  Evidence for host genetic regulation of altered lipid metabolism in experimental toxoplasmosis supported with gene data mining results.

Authors:  Ivan Milovanović; Miloš Busarčević; Alexander Trbovich; Vladimir Ivović; Aleksandra Uzelac; Olgica Djurković-Djaković
Journal:  PLoS One       Date:  2017-05-01       Impact factor: 3.240

8.  Changes in the proteomic profiles of mouse brain after infection with cyst-forming Toxoplasma gondii.

Authors:  Dong-Hui Zhou; Fu-Rong Zhao; Si-Yang Huang; Min-Jun Xu; Hui-Qun Song; Chunlei Su; Xing-Quan Zhu
Journal:  Parasit Vectors       Date:  2013-04-12       Impact factor: 3.876

9.  Characterization of mouse brain microRNAs after infection with cyst-forming Toxoplasma gondii.

Authors:  Min-Jun Xu; Dong-Hui Zhou; Alasdair J Nisbet; Si-Yang Huang; Yi-Fan Fan; Xing-Quan Zhu
Journal:  Parasit Vectors       Date:  2013-05-29       Impact factor: 3.876

10.  Toxoplasma gondii 70 kDa heat shock protein: systemic detection is associated with the death of the parasites by the immune response and its increased expression in the brain is associated with parasite replication.

Authors:  Paulo Victor Czarnewski Barenco; Elaine Vicente Lourenço; Jair Pereira Cunha-Júnior; Karine Cristine Almeida; Maria Cristina Roque-Barreira; Deise Aparecida Oliveira Silva; Ester Cristina Borges Araújo; Loyane Bertagnolli Coutinho; Mário Cézar Oliveira; Tiago Wilson Patriarca Mineo; José Roberto Mineo; Neide Maria Silva
Journal:  PLoS One       Date:  2014-05-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.